Bostancı, Evrim Zeynep Kamil Eğitim ve Araştırma Hastanesi - Kadın Hastalıkları ve Doğum Kliniği, Turkey , Ayas, Selçuk Zeynep Kamil Eğitim ve Araştırma Hastanesi - Kadın Hastalıkları ve Doğum Kliniği, Turkey , Gürbüz, Telce Ayşen Zeynep Kamil Eğitim ve Araştırma Hastanesi - Kadın Hastalıkları ve Doğum Kliniği, Turkey , Gürbüz, Ayşe Zeynep Kamil Eğitim ve Araştırma Hastanesi - Kadın Hastalıkları ve Doğum Kliniği, Turkey , Karateke, Ateş Zeynep Kamil Eğitim ve Araştırma Hastanesi - Kadın Hastalıkları ve Doğum Kliniği, Turkey

Retrospective analysis of 29 cases with uterine sarcoma: A single center experience

27184

Objective: To determine the recurrence and survival rates of uterine sarcomas according to stages, treatment methods, histological type.Methods: In this study 29 patients were included who were diagnosed with uterine sarcoma at Zeynep Kamil Women and Children Diseases Hospital between 2001 and 2011. Demographic data of patients, treatment and diagnosis process were investigated retrospectively by accessing the file of patients. Disease progression, survival time, recurrence status was learned by calling. Results were analyzed statistically.Results: Average age of patients were 51, 2 (± 13SD). Most of the patients were in postmenopausal (n=20, 68.9%). The most frequently (72.3%) complain was vaginal bleeding. 51.7% of patients were stage I and 34.4% of patients were stage 3 according to staging FIGO 2009. Twenty-two of the patients were treated with total abdominal hysterectomy (TAH)+ bilateral salpingo-oophorectomy (BSO)+bilateral pelvic and paraaortic lymphadenectomy (BPPLND) and omentectomy. Mean tumor size were 10, 2(±8.5) cm. 34,4% of patients (n = 10) patients had lymph node involvement. Respectively, after the operation, the average life expectancy of 3.2 years. Twelve patients (41.37%) died until data collected up to December 2013.Conclusion: Uterine sarcomas have poor prognosis even at early stages. Each histological type must be evaluated separately. The role of adjuvant therapy is controversial.

175

Uterine sarcomas , leimyosarcoma , survival

Dicle Medical Journal

180